
Sara Elizabeth Townsley
Examiner (ID: 6921, Phone: (571)270-7672 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1613, 1612, 1629 |
| Total Applications | 566 |
| Issued Applications | 109 |
| Pending Applications | 100 |
| Abandoned Applications | 361 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18374253
[patent_doc_number] => 20230149330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => SLEEP QUALITY IMPROVER
[patent_app_type] => utility
[patent_app_number] => 17/995333
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995333 | SLEEP QUALITY IMPROVER | Apr 12, 2021 | Pending |
Array
(
[id] => 18466923
[patent_doc_number] => 20230201203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHODS OF TREATMENT USING ANTIFOLATES AND PHARMACEUTICAL FORMULATIONS COMPRISING ANTIFOLATES
[patent_app_type] => utility
[patent_app_number] => 17/995418
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995418 | METHODS OF TREATMENT USING ANTIFOLATES AND PHARMACEUTICAL FORMULATIONS COMPRISING ANTIFOLATES | Apr 8, 2021 | Pending |
Array
(
[id] => 20607054
[patent_doc_number] => 12582633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Methods of treating severe acute respiratory syndrome
[patent_app_type] => utility
[patent_app_number] => 17/995604
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3885
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995604 | Methods of treating severe acute respiratory syndrome | Apr 7, 2021 | Issued |
Array
(
[id] => 18363128
[patent_doc_number] => 20230144719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => METHODS OF TREATING SARS-COV-2 INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/995602
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995602
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995602 | Methods of treating SARS-CoV-2 infections | Apr 7, 2021 | Issued |
Array
(
[id] => 18550744
[patent_doc_number] => 20230248744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => 25-HYDROXYVITAMIN D2 AND/OR D3 FOR USE IN OBESITY
[patent_app_type] => utility
[patent_app_number] => 17/917498
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 1149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917498 | 25-HYDROXYVITAMIN D2 AND/OR D3 FOR USE IN OBESITY | Apr 5, 2021 | Pending |
Array
(
[id] => 20788570
[patent_doc_number] => 12662475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-23
[patent_title] => Difluorocyclohexyl derivatives as IL-17 modulators
[patent_app_type] => utility
[patent_app_number] => 17/995495
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43299
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995495 | Difluorocyclohexyl derivatives as IL-17 modulators | Apr 5, 2021 | Issued |
Array
(
[id] => 20701328
[patent_doc_number] => 12624028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)
[patent_app_type] => utility
[patent_app_number] => 17/916405
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60644
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 606
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916405 | 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) | Apr 1, 2021 | Issued |
Array
(
[id] => 18483474
[patent_doc_number] => 20230210769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHODS OF TREATMENT USING NICLOSAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/995115
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995115 | METHODS OF TREATMENT USING NICLOSAMIDE | Mar 31, 2021 | Pending |
Array
(
[id] => 18723547
[patent_doc_number] => 20230337663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => AGRICULTURAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/915954
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915954
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915954 | AGRICULTURAL COMPOSITION | Mar 31, 2021 | Abandoned |
Array
(
[id] => 18449421
[patent_doc_number] => 20230190697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS FOR TREATING VIRAL INFECTIONS WITH NAFAMOSTAT
[patent_app_type] => utility
[patent_app_number] => 17/995020
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995020 | METHODS FOR TREATING VIRAL INFECTIONS WITH NAFAMOSTAT | Mar 30, 2021 | Pending |
Array
(
[id] => 18336016
[patent_doc_number] => 20230127965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS FOR TREATING, AMELIORATING, OR PREVENTING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/915838
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915838
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915838 | METHODS FOR TREATING, AMELIORATING, OR PREVENTING VIRAL INFECTIONS | Mar 29, 2021 | Pending |
Array
(
[id] => 18335754
[patent_doc_number] => 20230127703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/907722
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907722
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907722 | THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION | Mar 25, 2021 | Pending |
Array
(
[id] => 18466899
[patent_doc_number] => 20230201179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => AGENT FOR TREATING CONTRAST-INDUCED ACUTE KIDNEY INJURY
[patent_app_type] => utility
[patent_app_number] => 17/917689
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917689 | AGENT FOR TREATING CONTRAST-INDUCED ACUTE KIDNEY INJURY | Mar 22, 2021 | Pending |
Array
(
[id] => 20432177
[patent_doc_number] => 12501895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Composition for cryopreservation of myocardial cells
[patent_app_type] => utility
[patent_app_number] => 17/995409
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 1058
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995409 | Composition for cryopreservation of myocardial cells | Mar 11, 2021 | Issued |
Array
(
[id] => 18657606
[patent_doc_number] => 20230303523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => METHOD FOR PREPARING PYROTINIB
[patent_app_type] => utility
[patent_app_number] => 18/041160
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041160
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041160 | Method for preparing pyrotinib | Mar 4, 2021 | Issued |
Array
(
[id] => 18020515
[patent_doc_number] => 20220372014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => NEUROPROTECTIVE COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/765418
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765418 | NEUROPROTECTIVE COMPOUNDS AND METHODS OF USE THEREOF | Sep 29, 2020 | Pending |
Array
(
[id] => 11038784
[patent_doc_number] => 20160235741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'METHOD FOR TREATING HYPERTENSION'
[patent_app_type] => utility
[patent_app_number] => 15/141381
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10114
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15141381
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/141381 | Method for treating hypertension | Apr 27, 2016 | Issued |
Array
(
[id] => 10979915
[patent_doc_number] => 20160176859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'High-Throughput Assay for Identifying Small Molecules that Modulate AMP-activated Protein Kinase (AMPK)'
[patent_app_type] => utility
[patent_app_number] => 15/040412
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21404
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040412
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/040412 | High-Throughput Assay for Identifying Small Molecules that Modulate AMP-activated Protein Kinase (AMPK) | Feb 9, 2016 | Abandoned |
Array
(
[id] => 10742697
[patent_doc_number] => 20160088846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/962128
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21614
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962128
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/962128 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | Dec 7, 2015 | Abandoned |
Array
(
[id] => 10677852
[patent_doc_number] => 20160023997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'ABSORBABLE POLYURETHANES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/874387
[patent_app_country] => US
[patent_app_date] => 2015-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15696
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14874387
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/874387 | ABSORBABLE POLYURETHANES AND METHODS OF USE THEREOF | Oct 2, 2015 | Abandoned |